A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment

NCT04011475 · clinicaltrials.gov ↗

COMPLETED

Status

1617

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium + Olodaterol
DRUG: Other LABA/LAMA
DRUG: LAMA

Sponsor

Boehringer Ingelheim